189 related articles for article (PubMed ID: 1336949)
1. Synergy of itraconazole with macrophages in killing Blastomyces dermatitidis.
Brummer E; Bhagavathula PR; Hanson LH; Stevens DA
Antimicrob Agents Chemother; 1992 Nov; 36(11):2487-92. PubMed ID: 1336949
[TBL] [Abstract][Full Text] [Related]
2. Susceptibilities of clinical and laboratory isolates of Blastomyces dermatitidis to ketoconazole, itraconazole, and fluconazole.
Chapman SW; Rogers PD; Rinaldi MG; Sullivan DC
Antimicrob Agents Chemother; 1998 Apr; 42(4):978-80. PubMed ID: 9559827
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo activities of SCH 56592 against Blastomyces dermatitidis.
Sugar AM; Liu XP
Antimicrob Agents Chemother; 1996 May; 40(5):1314-6. PubMed ID: 8723494
[TBL] [Abstract][Full Text] [Related]
4. In-vitro studies with SF 86-327, a new orally active allylamine derivative.
Shadomy S; Espinel-Ingroff A; Gebhart RJ
Sabouraudia; 1985 Apr; 23(2):125-32. PubMed ID: 2990057
[TBL] [Abstract][Full Text] [Related]
5. In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum.
Li RK; Ciblak MA; Nordoff N; Pasarell L; Warnock DW; McGinnis MR
Antimicrob Agents Chemother; 2000 Jun; 44(6):1734-6. PubMed ID: 10817743
[TBL] [Abstract][Full Text] [Related]
6. Fungicidal activity of murine broncho-alveolar macrophages against Blastomyces dermatitidis.
Sugar AM; Brummer E; Stevens DA
J Med Microbiol; 1986 Feb; 21(1):7-11. PubMed ID: 3950963
[TBL] [Abstract][Full Text] [Related]
7. Activity of ICI 195,739, a new oral triazole, compared with that of ketoconazole in the therapy of experimental murine blastomycosis.
Tucker RM; Hanson LH; Brummer E; Stevens DA
Antimicrob Agents Chemother; 1989 Apr; 33(4):573-5. PubMed ID: 2729949
[TBL] [Abstract][Full Text] [Related]
8. Activation of peritoneal macrophages by concanavalin A or Mycobacterium bovis BCG for fungicidal activity against Blastomyces dermatitidis and effect of specific antibody and complement.
Brummer E; Sugar AM; Stevens DA
Infect Immun; 1983 Feb; 39(2):817-22. PubMed ID: 6832821
[TBL] [Abstract][Full Text] [Related]
9. Activity of amphotericin B and intraconazole against intraphagocytic Candida albicans.
Ponce E; Pechère JC
Eur J Clin Microbiol Infect Dis; 1990 Oct; 9(10):738-44. PubMed ID: 2175704
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of itraconazole in blastomycosis in a murine model and comparison with ketoconazole.
Arathoon EG; Brummer E; Stevens DA
Mycoses; 1989; 32 Suppl 1():109-12. PubMed ID: 2561182
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of fungal pathogenicity: correlation of virulence in vivo, susceptibility to killing by polymorphonuclear neutrophils in vitro, and neutrophil superoxide anion induction among Blastomyces dermatitidis isolates.
Morrison CJ; Stevens DA
Infect Immun; 1991 Aug; 59(8):2744-9. PubMed ID: 1649799
[TBL] [Abstract][Full Text] [Related]
12. Enhanced oxidative burst in immunologically activated but not elicited polymorphonuclear leukocytes correlates with fungicidal activity.
Brummer E; Sugar AM; Stevens DA
Infect Immun; 1985 Aug; 49(2):396-401. PubMed ID: 3894234
[TBL] [Abstract][Full Text] [Related]
13. Effect of amphotericin B, fluconazole and itraconazole on intracellular Candida albicans and germ tube development in macrophages.
Van 't Wout JW; Meynaar I; Linde I; Poell R; Mattie H; Van Furth R
J Antimicrob Chemother; 1990 May; 25(5):803-11. PubMed ID: 2165051
[TBL] [Abstract][Full Text] [Related]
14. Activities of the triazole D0870 in vitro and against murine blastomycosis.
Clemons KV; Hanson LH; Stevens DA
Antimicrob Agents Chemother; 1993 May; 37(5):1177-9. PubMed ID: 8517710
[TBL] [Abstract][Full Text] [Related]
15. In vitro studies with R 51,211 (itraconazole).
Espinel-Ingroff A; Shadomy S; Gebhart RJ
Antimicrob Agents Chemother; 1984 Jul; 26(1):5-9. PubMed ID: 6089654
[TBL] [Abstract][Full Text] [Related]
16. Fungicidal mechanisms of activated macrophages: evidence for nonoxidative mechanisms for killing of Blastomyces dermatitidis.
Brummer E; Stevens DA
Infect Immun; 1987 Dec; 55(12):3221-4. PubMed ID: 3316037
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
Gupta AK; Kohli Y
Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
[TBL] [Abstract][Full Text] [Related]
18. In vitro antifungal activity of BMS-181184 against systemic isolates of Candida, Cryptococcus, and Blastomyces species.
Karlowsky JA; Zhanel GG; Balko TV; Zelenitsky SA; Kabani AM; Hoban DJ
Diagn Microbiol Infect Dis; 1997 Aug; 28(4):179-82. PubMed ID: 9327245
[TBL] [Abstract][Full Text] [Related]
19. Immunoadjuvant effects of Blastomyces dermatitidis against EL 4 lymphoma in C57BL/6J mice.
McDaniel LS; Cozad GC
J Natl Cancer Inst; 1982 Dec; 69(6):1337-42. PubMed ID: 6958909
[TBL] [Abstract][Full Text] [Related]
20. Immunological activation of polymorphonuclear neutrophils for fungal killing: studies with murine cells and blastomyces dermatitidis in vitro.
Brummer E; Sugar AM; Stevens DA
J Leukoc Biol; 1984 Oct; 36(4):505-20. PubMed ID: 6384406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
